Fingerprint
Dive into the research topics of 'Who benefits most from adjuvant interferon treatment for melanoma?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Who benefits most from adjuvant interferon treatment for melanoma?
Helen Gogas*, Huseyin Abali, Paolo A. Ascierto, Lev Demidov, Hubert Pehamberger, Caroline Robert, Jacob Schachter, Alexander M.M. Eggermont, Axel Hauschild, Enrique Espinosa
*Corresponding author for this work
- National and Kapodistrian University of Athens
- Baskent University
- IRCCS Istituto nazionale tumori Fondazione Giovanni Pascale - Napoli
- Russian Academy of Medical Sciences - N.N. Blokhin Russian Cancer Research Center
- Medical University of Vienna
- Institut de Cancérologie Gustave Roussy
- Sheba Medical Center at Tel Hashomer
- Kiel University
- Hospital Universitario La Paz
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations